Jeremy Barowsky1, Thomas L Schwartz. 1. Dr. Barowsky is Clinical Assistant Instructor from Harvard Longwood in Boston, Massachusetts.
Abstract
DESIGN, SETTING, PARTICIPANTS: This paper is a review article that collects and synthesizes up-to-date information about the practice of augmenting and combining medications in regards to treatment resistant major depressive disorder. The authors have written the paper in an evidence-based model in order to show the reader where adequate data exists in regards to these strategies. A thorough MEDLINE search was utilized to collect many papers dedicated to this area of study spanning 1989-2005. MEASUREMENTS: Papers were divided based upon drug intervention and scientific merit, where randomized controlled trials were given the most evidence-based weight and case studies the least. RESULTS: The literature review data is divided into augmentation and combination strategies in descending order of scientific stringency. For augmentation, lithium, antipsychotic, and thyroid addition has the most empirical support. For combination strategies, heterocyclic addition is the best studied. CONCLUSION: There is much literature regarding complex medication management of major depression that is generally supportive of this practice. However, much of the literature contains underpowered and uncontrolled studies.
DESIGN, SETTING, PARTICIPANTS: This paper is a review article that collects and synthesizes up-to-date information about the practice of augmenting and combining medications in regards to treatment resistant major depressive disorder. The authors have written the paper in an evidence-based model in order to show the reader where adequate data exists in regards to these strategies. A thorough MEDLINE search was utilized to collect many papers dedicated to this area of study spanning 1989-2005. MEASUREMENTS: Papers were divided based upon drug intervention and scientific merit, where randomized controlled trials were given the most evidence-based weight and case studies the least. RESULTS: The literature review data is divided into augmentation and combination strategies in descending order of scientific stringency. For augmentation, lithium, antipsychotic, and thyroid addition has the most empirical support. For combination strategies, heterocyclic addition is the best studied. CONCLUSION: There is much literature regarding complex medication management of major depression that is generally supportive of this practice. However, much of the literature contains underpowered and uncontrolled studies.
Entities:
Keywords:
antidepressant; augmentation; combination; major depression; polypharmacy
Authors: Lauren B Marangell; Christopher R Johnson; Barbara Kertz; Holly A Zboyan; James M Martinez Journal: J Clin Psychiatry Date: 2002-05 Impact factor: 4.384
Authors: Sara A Corya; Scott W Andersen; Holland C Detke; Linda S Kelly; Luann E Van Campen; Todd M Sanger; Douglas J Williamson; Sanjay Dubé Journal: J Clin Psychiatry Date: 2003-11 Impact factor: 4.384
Authors: Jeroen Govaerts; Julie Boeyckens; Astrid Lammens; Annelies Gilis; Filip Bouckaert; Marc De Hert; Jan De Lepeleire; Brendon Stubbs; Franciska Desplenter Journal: Ther Adv Psychopharmacol Date: 2021-03-19
Authors: Anderson Camargo; Ana Paula Dalmagro; Daiane B Fraga; Julia M Rosa; Ana Lúcia B Zeni; Manuella P Kaster; Ana Lúcia S Rodrigues Journal: Psychopharmacology (Berl) Date: 2021-08-03 Impact factor: 4.530
Authors: Amber N Edinoff; Natalie W Wu; Benjamin S Maxey; Amy L Ren; Kenna N Leethy; Brook Girma; Amira Odisho; Jessica S Kaye; Aaron J Kaye; Adam M Kaye; Alan D Kaye; George Mychaskiw; Omar Viswanath; Ivan Urits Journal: Psychopharmacol Bull Date: 2021-03-16